Global Pregnenolone

Pregnenolone Comprehensive Study by Type (Purity 90%, Purity 99%, Others), Application (Synthesis of Steroidal Drugs, Intermediates of Steroid Drugs) Players and Region - Global Market Outlook to 2030

Pregnenolone Market by XX Submarkets | Forecast Years 2024-2030  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Pregnenolone Market Scope
Pregnenolone is also called 3-alpha-hydroxy-5-beta-pregnen-20-one goes about as an antecedent for DHEA, progesterone, estrogen, testosterone and cortisol. Pregnenolone is created normally in the body from the cholesterol and with age the degrees of pregnenolone diminishes. Pregnenolone helps in regularization of harmony among restraint and excitation in the sensory system. Besides, pregnenolone expands the development of neurons, neurological recuperation just as improving the arrangement of new neurotransmitters. Pregnenolone builds the measure of profound deep sleep in people.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)
Key Companies ProfiledCaptek (United States), Parchem fine and specialty chemicals (United States), FCAD Group (Caming Pharmaceutical) (United Kingdom), TCI (India), Sigma-Aldrich (United States), Boc Sciences (United States), BLD Pharm (India), Acadechem (China), Yuhao Chemical (China) and AN PharmaTech (China)
CAGR%


The rising number of players expected to enter the global market is predicted to enhance the competition level as well as encourage the growth of the overall market in the near future. Players are anticipated to focus on the development of new compounds, which is likely to encourage the growth of the global market throughout the forecast period. Research Analyst at AMA estimates that United States and Chinese Players will contribute to the maximum growth of Global Pregnenolone market throughout the predicted period.

Captek (United States), Parchem fine and specialty chemicals (United States), FCAD Group (Caming Pharmaceutical) (United Kingdom), TCI (India), Sigma-Aldrich (United States), Boc Sciences (United States), BLD Pharm (India), Acadechem (China), Yuhao Chemical (China) and AN PharmaTech (China) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Hangzhou APIChem Technology, Wubei-Biochem, Chemenu Inc., Combi-Blocks, Hairui Chemical and Biosynth.

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.

Segmentation Overview
The study have segmented the market of Global Pregnenolone market by Type , by Application (Synthesis of Steroidal Drugs and Intermediates of Steroid Drugs) and Region with country level break-up.

On the basis of geography, the market of Pregnenolone has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). region held largest market share in the year 2023.

Market Leaders and their expansionary development strategies
In 2022, Thorne a health technology company acquired PreCon Health, Inc. a company focuses on scientific discovery, innovation, and advancing safe and effective products that support healthy brain function. This acquisition strengthened brain health portfolio with unparalleled access to brain health products.
In


Influencing Trend:
Upcoming advancement in new treatment

Market Growth Drivers:
Rising geriatric populace and related occurrences of neurological ailment determination are probably going to help the utilization of pregnenolone

Challenges:
Allergic problem associated with the product

Restraints:
Availability of substitute

Opportunities:
Provides anti-aging effects as well as immunity enhancement

Key Target Audience
Manufacture, Providers, Suppliers and Others

Report Objectives / Segmentation Covered

By Type
  • Purity 90%
  • Purity 99%
  • Others
By Application
  • Synthesis of Steroidal Drugs
  • Intermediates of Steroid Drugs
By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising geriatric populace and related occurrences of neurological ailment determination are probably going to help the utilization of pregnenolone
    • 3.3. Market Challenges
      • 3.3.1. Allergic problem associated with the product
    • 3.4. Market Trends
      • 3.4.1. Upcoming advancement in new treatment
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Pregnenolone, by Type, Application and Region (value) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Pregnenolone (Value)
      • 5.2.1. Global Pregnenolone by: Type (Value)
        • 5.2.1.1. Purity 90%
        • 5.2.1.2. Purity 99%
        • 5.2.1.3. Others
      • 5.2.2. Global Pregnenolone by: Application (Value)
        • 5.2.2.1. Synthesis of Steroidal Drugs
        • 5.2.2.2. Intermediates of Steroid Drugs
      • 5.2.3. Global Pregnenolone Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
  • 6. Pregnenolone: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Captek (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Parchem fine and specialty chemicals (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. FCAD Group (Caming Pharmaceutical) (United Kingdom)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. TCI (India)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Sigma-Aldrich (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Boc Sciences (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. BLD Pharm (India)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Acadechem (China)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Yuhao Chemical (China)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. AN PharmaTech (China)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Pregnenolone Sale, by Type, Application and Region (value) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Pregnenolone (Value)
      • 7.2.1. Global Pregnenolone by: Type (Value)
        • 7.2.1.1. Purity 90%
        • 7.2.1.2. Purity 99%
        • 7.2.1.3. Others
      • 7.2.2. Global Pregnenolone by: Application (Value)
        • 7.2.2.1. Synthesis of Steroidal Drugs
        • 7.2.2.2. Intermediates of Steroid Drugs
      • 7.2.3. Global Pregnenolone Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Pregnenolone: by Type(USD Million)
  • Table 2. Pregnenolone Purity 90% , by Region USD Million (2018-2023)
  • Table 3. Pregnenolone Purity 99% , by Region USD Million (2018-2023)
  • Table 4. Pregnenolone Others , by Region USD Million (2018-2023)
  • Table 5. Pregnenolone: by Application(USD Million)
  • Table 6. Pregnenolone Synthesis of Steroidal Drugs , by Region USD Million (2018-2023)
  • Table 7. Pregnenolone Intermediates of Steroid Drugs , by Region USD Million (2018-2023)
  • Table 8. South America Pregnenolone, by Country USD Million (2018-2023)
  • Table 9. South America Pregnenolone, by Type USD Million (2018-2023)
  • Table 10. South America Pregnenolone, by Application USD Million (2018-2023)
  • Table 11. Brazil Pregnenolone, by Type USD Million (2018-2023)
  • Table 12. Brazil Pregnenolone, by Application USD Million (2018-2023)
  • Table 13. Argentina Pregnenolone, by Type USD Million (2018-2023)
  • Table 14. Argentina Pregnenolone, by Application USD Million (2018-2023)
  • Table 15. Rest of South America Pregnenolone, by Type USD Million (2018-2023)
  • Table 16. Rest of South America Pregnenolone, by Application USD Million (2018-2023)
  • Table 17. Asia Pacific Pregnenolone, by Country USD Million (2018-2023)
  • Table 18. Asia Pacific Pregnenolone, by Type USD Million (2018-2023)
  • Table 19. Asia Pacific Pregnenolone, by Application USD Million (2018-2023)
  • Table 20. China Pregnenolone, by Type USD Million (2018-2023)
  • Table 21. China Pregnenolone, by Application USD Million (2018-2023)
  • Table 22. Japan Pregnenolone, by Type USD Million (2018-2023)
  • Table 23. Japan Pregnenolone, by Application USD Million (2018-2023)
  • Table 24. India Pregnenolone, by Type USD Million (2018-2023)
  • Table 25. India Pregnenolone, by Application USD Million (2018-2023)
  • Table 26. South Korea Pregnenolone, by Type USD Million (2018-2023)
  • Table 27. South Korea Pregnenolone, by Application USD Million (2018-2023)
  • Table 28. Taiwan Pregnenolone, by Type USD Million (2018-2023)
  • Table 29. Taiwan Pregnenolone, by Application USD Million (2018-2023)
  • Table 30. Australia Pregnenolone, by Type USD Million (2018-2023)
  • Table 31. Australia Pregnenolone, by Application USD Million (2018-2023)
  • Table 32. Rest of Asia-Pacific Pregnenolone, by Type USD Million (2018-2023)
  • Table 33. Rest of Asia-Pacific Pregnenolone, by Application USD Million (2018-2023)
  • Table 34. Europe Pregnenolone, by Country USD Million (2018-2023)
  • Table 35. Europe Pregnenolone, by Type USD Million (2018-2023)
  • Table 36. Europe Pregnenolone, by Application USD Million (2018-2023)
  • Table 37. Germany Pregnenolone, by Type USD Million (2018-2023)
  • Table 38. Germany Pregnenolone, by Application USD Million (2018-2023)
  • Table 39. France Pregnenolone, by Type USD Million (2018-2023)
  • Table 40. France Pregnenolone, by Application USD Million (2018-2023)
  • Table 41. Italy Pregnenolone, by Type USD Million (2018-2023)
  • Table 42. Italy Pregnenolone, by Application USD Million (2018-2023)
  • Table 43. United Kingdom Pregnenolone, by Type USD Million (2018-2023)
  • Table 44. United Kingdom Pregnenolone, by Application USD Million (2018-2023)
  • Table 45. Netherlands Pregnenolone, by Type USD Million (2018-2023)
  • Table 46. Netherlands Pregnenolone, by Application USD Million (2018-2023)
  • Table 47. Rest of Europe Pregnenolone, by Type USD Million (2018-2023)
  • Table 48. Rest of Europe Pregnenolone, by Application USD Million (2018-2023)
  • Table 49. MEA Pregnenolone, by Country USD Million (2018-2023)
  • Table 50. MEA Pregnenolone, by Type USD Million (2018-2023)
  • Table 51. MEA Pregnenolone, by Application USD Million (2018-2023)
  • Table 52. Middle East Pregnenolone, by Type USD Million (2018-2023)
  • Table 53. Middle East Pregnenolone, by Application USD Million (2018-2023)
  • Table 54. Africa Pregnenolone, by Type USD Million (2018-2023)
  • Table 55. Africa Pregnenolone, by Application USD Million (2018-2023)
  • Table 56. North America Pregnenolone, by Country USD Million (2018-2023)
  • Table 57. North America Pregnenolone, by Type USD Million (2018-2023)
  • Table 58. North America Pregnenolone, by Application USD Million (2018-2023)
  • Table 59. United States Pregnenolone, by Type USD Million (2018-2023)
  • Table 60. United States Pregnenolone, by Application USD Million (2018-2023)
  • Table 61. Canada Pregnenolone, by Type USD Million (2018-2023)
  • Table 62. Canada Pregnenolone, by Application USD Million (2018-2023)
  • Table 63. Mexico Pregnenolone, by Type USD Million (2018-2023)
  • Table 64. Mexico Pregnenolone, by Application USD Million (2018-2023)
  • Table 65. Company Basic Information, Sales Area and Its Competitors
  • Table 66. Company Basic Information, Sales Area and Its Competitors
  • Table 67. Company Basic Information, Sales Area and Its Competitors
  • Table 68. Company Basic Information, Sales Area and Its Competitors
  • Table 69. Company Basic Information, Sales Area and Its Competitors
  • Table 70. Company Basic Information, Sales Area and Its Competitors
  • Table 71. Company Basic Information, Sales Area and Its Competitors
  • Table 72. Company Basic Information, Sales Area and Its Competitors
  • Table 73. Company Basic Information, Sales Area and Its Competitors
  • Table 74. Company Basic Information, Sales Area and Its Competitors
  • Table 75. Pregnenolone: by Type(USD Million)
  • Table 76. Pregnenolone Purity 90% , by Region USD Million (2025-2030)
  • Table 77. Pregnenolone Purity 99% , by Region USD Million (2025-2030)
  • Table 78. Pregnenolone Others , by Region USD Million (2025-2030)
  • Table 79. Pregnenolone: by Application(USD Million)
  • Table 80. Pregnenolone Synthesis of Steroidal Drugs , by Region USD Million (2025-2030)
  • Table 81. Pregnenolone Intermediates of Steroid Drugs , by Region USD Million (2025-2030)
  • Table 82. South America Pregnenolone, by Country USD Million (2025-2030)
  • Table 83. South America Pregnenolone, by Type USD Million (2025-2030)
  • Table 84. South America Pregnenolone, by Application USD Million (2025-2030)
  • Table 85. Brazil Pregnenolone, by Type USD Million (2025-2030)
  • Table 86. Brazil Pregnenolone, by Application USD Million (2025-2030)
  • Table 87. Argentina Pregnenolone, by Type USD Million (2025-2030)
  • Table 88. Argentina Pregnenolone, by Application USD Million (2025-2030)
  • Table 89. Rest of South America Pregnenolone, by Type USD Million (2025-2030)
  • Table 90. Rest of South America Pregnenolone, by Application USD Million (2025-2030)
  • Table 91. Asia Pacific Pregnenolone, by Country USD Million (2025-2030)
  • Table 92. Asia Pacific Pregnenolone, by Type USD Million (2025-2030)
  • Table 93. Asia Pacific Pregnenolone, by Application USD Million (2025-2030)
  • Table 94. China Pregnenolone, by Type USD Million (2025-2030)
  • Table 95. China Pregnenolone, by Application USD Million (2025-2030)
  • Table 96. Japan Pregnenolone, by Type USD Million (2025-2030)
  • Table 97. Japan Pregnenolone, by Application USD Million (2025-2030)
  • Table 98. India Pregnenolone, by Type USD Million (2025-2030)
  • Table 99. India Pregnenolone, by Application USD Million (2025-2030)
  • Table 100. South Korea Pregnenolone, by Type USD Million (2025-2030)
  • Table 101. South Korea Pregnenolone, by Application USD Million (2025-2030)
  • Table 102. Taiwan Pregnenolone, by Type USD Million (2025-2030)
  • Table 103. Taiwan Pregnenolone, by Application USD Million (2025-2030)
  • Table 104. Australia Pregnenolone, by Type USD Million (2025-2030)
  • Table 105. Australia Pregnenolone, by Application USD Million (2025-2030)
  • Table 106. Rest of Asia-Pacific Pregnenolone, by Type USD Million (2025-2030)
  • Table 107. Rest of Asia-Pacific Pregnenolone, by Application USD Million (2025-2030)
  • Table 108. Europe Pregnenolone, by Country USD Million (2025-2030)
  • Table 109. Europe Pregnenolone, by Type USD Million (2025-2030)
  • Table 110. Europe Pregnenolone, by Application USD Million (2025-2030)
  • Table 111. Germany Pregnenolone, by Type USD Million (2025-2030)
  • Table 112. Germany Pregnenolone, by Application USD Million (2025-2030)
  • Table 113. France Pregnenolone, by Type USD Million (2025-2030)
  • Table 114. France Pregnenolone, by Application USD Million (2025-2030)
  • Table 115. Italy Pregnenolone, by Type USD Million (2025-2030)
  • Table 116. Italy Pregnenolone, by Application USD Million (2025-2030)
  • Table 117. United Kingdom Pregnenolone, by Type USD Million (2025-2030)
  • Table 118. United Kingdom Pregnenolone, by Application USD Million (2025-2030)
  • Table 119. Netherlands Pregnenolone, by Type USD Million (2025-2030)
  • Table 120. Netherlands Pregnenolone, by Application USD Million (2025-2030)
  • Table 121. Rest of Europe Pregnenolone, by Type USD Million (2025-2030)
  • Table 122. Rest of Europe Pregnenolone, by Application USD Million (2025-2030)
  • Table 123. MEA Pregnenolone, by Country USD Million (2025-2030)
  • Table 124. MEA Pregnenolone, by Type USD Million (2025-2030)
  • Table 125. MEA Pregnenolone, by Application USD Million (2025-2030)
  • Table 126. Middle East Pregnenolone, by Type USD Million (2025-2030)
  • Table 127. Middle East Pregnenolone, by Application USD Million (2025-2030)
  • Table 128. Africa Pregnenolone, by Type USD Million (2025-2030)
  • Table 129. Africa Pregnenolone, by Application USD Million (2025-2030)
  • Table 130. North America Pregnenolone, by Country USD Million (2025-2030)
  • Table 131. North America Pregnenolone, by Type USD Million (2025-2030)
  • Table 132. North America Pregnenolone, by Application USD Million (2025-2030)
  • Table 133. United States Pregnenolone, by Type USD Million (2025-2030)
  • Table 134. United States Pregnenolone, by Application USD Million (2025-2030)
  • Table 135. Canada Pregnenolone, by Type USD Million (2025-2030)
  • Table 136. Canada Pregnenolone, by Application USD Million (2025-2030)
  • Table 137. Mexico Pregnenolone, by Type USD Million (2025-2030)
  • Table 138. Mexico Pregnenolone, by Application USD Million (2025-2030)
  • Table 139. Research Programs/Design for This Report
  • Table 140. Key Data Information from Secondary Sources
  • Table 141. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Pregnenolone: by Type USD Million (2018-2023)
  • Figure 5. Global Pregnenolone: by Application USD Million (2018-2023)
  • Figure 6. South America Pregnenolone Share (%), by Country
  • Figure 7. Asia Pacific Pregnenolone Share (%), by Country
  • Figure 8. Europe Pregnenolone Share (%), by Country
  • Figure 9. MEA Pregnenolone Share (%), by Country
  • Figure 10. North America Pregnenolone Share (%), by Country
  • Figure 11. Global Pregnenolone share by Players 2023 (%)
  • Figure 12. Global Pregnenolone share by Players (Top 3) 2023(%)
  • Figure 13. Global Pregnenolone share by Players (Top 5) 2023(%)
  • Figure 14. BCG Matrix for key Companies
  • Figure 15. Captek (United States) Revenue, Net Income and Gross profit
  • Figure 16. Captek (United States) Revenue: by Geography 2023
  • Figure 17. Parchem fine and specialty chemicals (United States) Revenue, Net Income and Gross profit
  • Figure 18. Parchem fine and specialty chemicals (United States) Revenue: by Geography 2023
  • Figure 19. FCAD Group (Caming Pharmaceutical) (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 20. FCAD Group (Caming Pharmaceutical) (United Kingdom) Revenue: by Geography 2023
  • Figure 21. TCI (India) Revenue, Net Income and Gross profit
  • Figure 22. TCI (India) Revenue: by Geography 2023
  • Figure 23. Sigma-Aldrich (United States) Revenue, Net Income and Gross profit
  • Figure 24. Sigma-Aldrich (United States) Revenue: by Geography 2023
  • Figure 25. Boc Sciences (United States) Revenue, Net Income and Gross profit
  • Figure 26. Boc Sciences (United States) Revenue: by Geography 2023
  • Figure 27. BLD Pharm (India) Revenue, Net Income and Gross profit
  • Figure 28. BLD Pharm (India) Revenue: by Geography 2023
  • Figure 29. Acadechem (China) Revenue, Net Income and Gross profit
  • Figure 30. Acadechem (China) Revenue: by Geography 2023
  • Figure 31. Yuhao Chemical (China) Revenue, Net Income and Gross profit
  • Figure 32. Yuhao Chemical (China) Revenue: by Geography 2023
  • Figure 33. AN PharmaTech (China) Revenue, Net Income and Gross profit
  • Figure 34. AN PharmaTech (China) Revenue: by Geography 2023
  • Figure 35. Global Pregnenolone: by Type USD Million (2025-2030)
  • Figure 36. Global Pregnenolone: by Application USD Million (2025-2030)
  • Figure 37. South America Pregnenolone Share (%), by Country
  • Figure 38. Asia Pacific Pregnenolone Share (%), by Country
  • Figure 39. Europe Pregnenolone Share (%), by Country
  • Figure 40. MEA Pregnenolone Share (%), by Country
  • Figure 41. North America Pregnenolone Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Captek (United States)
  • Parchem fine and specialty chemicals (United States)
  • FCAD Group (Caming Pharmaceutical) (United Kingdom)
  • TCI (India)
  • Sigma-Aldrich (United States)
  • Boc Sciences (United States)
  • BLD Pharm (India)
  • Acadechem (China)
  • Yuhao Chemical (China)
  • AN PharmaTech (China)
Additional players considered in the study are as follows:
Hangzhou APIChem Technology , Wubei-Biochem , Chemenu Inc. , Combi-Blocks , Hairui Chemical , Biosynth
Select User Access Type

Key Highlights of Report


Apr 2024 238 Pages 94 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Pregnenolone Quantitative research analysis
Global Pregnenolone Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The key segments that are playing vital role in Pregnenolone Market are by type [Purity 90%, Purity 99% and Others], by end use application [Synthesis of Steroidal Drugs and Intermediates of Steroid Drugs].
The Pregnenolone Market is gaining popularity and expected to see strong valuation by 2030.
  • Rising geriatric populace and related occurrences of neurological ailment determination are probably going to help the utilization of pregnenolone

Know More About Global Pregnenolone Report?

Have a Query? Click Here

Other Related Reports

Blood Banking Comprehensive Study by Type (Whole Blood, Red Blood Cell, Platelet, Plasma, Blood CellWhite), Function (Collection, Processing, Testing, Storage, Transportation), Bank Type (Private, Pu...
$ 3650
Rare Disease Drug Comprehensive Study by Type (Biologics, Non-Biologics), Application (Hospitals, Clinics, Others), Disease (Oncologic Diseases, Metabolic Diseases, Hematologic & Immunologic Diseases...
$ 3750
Prosthetic Foot Comprehensive Study by Type (Mechanical Foot, Microprocessor Foot), Application (Juveniles, Adults), Prosthetic Products (Lower Extremity Prosthetics, Liners, Sockets, Modular Compone...
$ 3500
Dynamic Compressive Plate Comprehensive Study by Type (Adult Compressive Plate, Children Compressive Plate), Application (Leg, Skull, Forearm, Arm), End users (Hospitals, Clinics), Materials (Titaniu...
$ 3500
Wound Cleanser Products Comprehensive Study by Application (Traumatic Ulcers, Diabetic Ulcers, Pressure Ulcers), End User (Hospital Inpatient Settings, Hospital Outpatient Settings, Ambulatory Surgi...
$ 3450
Disposable Surgical Gowns Comprehensive Study by Type (PP Non-woven material, SMS Non-woven material, Others), Application (Hospitals, Clinics, Others), Distribution Channel (Online Sales, Retail Pha...
$ 3450